• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance
 

TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance

Options
  • Details
  • Files
BORIS DOI
10.7892/boris.46044
Publisher DOI
10.1371/journal.ppat.1003900
PubMed ID
24453980
Description
Triggering receptor expressed on myeloid cells-1 (TREM-1) is a potent amplifier of pro-inflammatory innate immune reactions. While TREM-1-amplified responses likely aid an improved detection and elimination of pathogens, excessive production of cytokines and oxygen radicals can also severely harm the host. Studies addressing the pathogenic role of TREM-1 during endotoxin-induced shock or microbial sepsis have so far mostly relied on the administration of TREM-1 fusion proteins or peptides representing part of the extracellular domain of TREM-1. However, binding of these agents to the yet unidentified TREM-1 ligand could also impact signaling through alternative receptors. More importantly, controversial results have been obtained regarding the requirement of TREM-1 for microbial control. To unambiguously investigate the role of TREM-1 in homeostasis and disease, we have generated mice deficient in Trem1. Trem1(-/-) mice are viable, fertile and show no altered hematopoietic compartment. In CD4(+) T cell- and dextran sodium sulfate-induced models of colitis, Trem1(-/-) mice displayed significantly attenuated disease that was associated with reduced inflammatory infiltrates and diminished expression of pro-inflammatory cytokines. Trem1(-/-) mice also exhibited reduced neutrophilic infiltration and decreased lesion size upon infection with Leishmania major. Furthermore, reduced morbidity was observed for influenza virus-infected Trem1(-/-) mice. Importantly, while immune-associated pathologies were significantly reduced, Trem1(-/-) mice were equally capable of controlling infections with L. major, influenza virus, but also Legionella pneumophila as Trem1(+/+) controls. Our results not only demonstrate an unanticipated pathogenic impact of TREM-1 during a viral and parasitic infection, but also indicate that therapeutic blocking of TREM-1 in distinct inflammatory disorders holds considerable promise by blunting excessive inflammation while preserving the capacity for microbial control.
Date of Publication
2014-01
Publication Type
Article
Subject(s)
600 - Technology::610 - Medicine & health
500 - Science::570 - Life sciences; biology
Language(s)
en
Contributor(s)
Weber, Benjamin
Institut für Pathologie
Schuster, Steffen
Zysset, Daniel
Institut für Pathologie
Rihs, Silvia
Institut für Pathologie
Dickgreber, Nina
Institut für Pathologie
Schürch, Christianorcid-logo
Institut für Pathologie, Autopsie
Riether, Carstenorcid-logo
Departement Klinische Forschung, Forschungsgruppe Tumor-Immunologie
Siegrist, Mark
Departement Klinische Forschung, Forschungsgruppe Knochenbiologie & Orthopädische Forschung
Schneider, Christoph
Institut für Pharmakologie
Pawelski, Helga
Gurzeler, Ursina
Institut für Pharmakologie
Ziltener, Pascal
Genitsch Gratwohl, Veraorcid-logo
Institut für Pathologie, Klinische Pathologie
Tacchini-Cottier, Fabienne
Ochsenbein, Adrian
Universitätsklinik für Medizinische Onkologie
Hofstetter-Jenny, Willyorcid-logo
Departement Klinische Forschung, Forschungsgruppe Knochenbiologie & Orthopädische Forschung
Kopf, Manfred
Kaufmann, Thomasorcid-logo
Institut für Pharmakologie
Oxenius, Annette
Reith, Walter
Saurer, Leslie
Institut für Pathologie
Müller, Christophorcid-logo
Institut für Pathologie
Additional Credits
Institut für Pathologie, Klinische Pathologie
Universitätsklinik für Medizinische Onkologie
Departement Klinische Forschung, Forschungsgruppe Knochenbiologie & Orthopädische Forschung
Institut für Pharmakologie
Institut für Pathologie
Institut für Pathologie, Autopsie
Departement Klinische Forschung, Forschungsgruppe Tumor-Immunologie
Series
PLoS pathogens
Publisher
Public Library of Science
ISSN
1553-7366
Access(Rights)
open.access
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: 9f4e9a [ 5.02. 18:48]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo